Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity Jan. 2, 1998 No Comments
Lilly develops compounds for the common cold; selects development candidate Dec. 30, 1997 No Comments
Pfizer discovers potent, orally active human liver glycogen phosphorylase inhibitor Dec. 30, 1997 No Comments
RSS